The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency

Clinical Endocrinology

Volumn 59, Issue 3, 2003, Pages 380-387

  Suliman, Abdulwahab M ^a   Freaney, Rosemarie ^a   Smith, Thomas P ^a   McBrinn, Yvonne ^a   Murray, Barbara ^a   McKenna, T Joseph ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM ION; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; DEXAMETHASONE; ESTROGEN; FLUDROCORTISONE; GESTAGEN; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; LEVOTHYROXINE; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISOLONE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE REMODELING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MATHEMATICAL MODEL; MENOPAUSAL SYNDROME; OPEN STUDY; OSSIFICATION; OSTEOLYSIS; PANCREAS ISLET BETA CELL; PARATHYROID HORMONE BLOOD LEVEL; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; URINALYSIS;

ADRENAL INSUFFICIENCY; AMINO ACIDS; BIOLOGICAL MARKERS; BONE REMODELING; CALCIFEDIOL; CALCIUM; CASE-CONTROL STUDIES; COLLAGEN; COLLAGEN TYPE I; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDES;

EID: 0042326304     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01860.x     Document Type: Article

References (37)

1. Al-Shoumer, K.A., Beshayah, S.A., Niththyananthan, R. & Johnston, D.G. (1995) Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clinical Endocrinology, 42, 86-90.
2. Besser, G.M. & Jeffcoate, W.J. (1976) Endocrine and metabolic disease: adrenal disease. British Medical Journal, 21, 448-451.
3. Bonora, E., Moghetti, P., Zancanaro, C., Cigolini, M., Querena, M., Cacciatori, V., Corgnati, A. & Muggeo, M. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaeimc clamp and hyperinsulinaemic clamp studies. Journal of Clinical Endocrinology and Metabolism, 68, 374-378.
4. Canalis, E. & Giustina, A. (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. Journal of Clinical Endocrinology and Metabolism, 86, 5681-5685.
5. Chapuy, M.C., Schott, A.M., Garnero, P., Hans, D., Delmas, P.D., Meunier, P.J. & Epidos Study Group (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in wintertime. Journal of Clinical Endocrinology and Metabolism, 81, 1129-1133.
6. Cuneo, R.C. (1995) Current strategies for hormone replacement therapy for the hypopituitary patient. Medical Journal of Australia, 163, 539-541.
7. Dawson-Hughes, B., Harris, S.S. & Dallal, G.E. (1997) Plasma calcidiol, season and PTH concentrations in healthy elderly men and women. American Journal of Clinical Nutrition, 65, 67-71.
8. Dempster, D.W., Cosman, F., Parisien, M., Shen, V. & Lindsay, R. (1993) Anabolic actions of parathyroid hormone on bone. Endocrine Reviews, 14, 690-709.
9. Dennison, E., Hindmarsh, P., Fall, C., Kellingray, S., Barker, D., Phillips, D. & Cooper, C. (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. Journal of Clinical Endocrinology and Metabolism, 84, 3058-3063.
10. Di Somma, C., Pivonello, R., Loche, S., Faggiano, A., Marzullo, P., Di Sarno, A., Klain, M., Salvatore, M., Lombardi, G. & Colao, A. (2002) Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clinical Endocrinology, 56, 153-158.
11. Endres, D.B., Morgan, C.H., Garry, P.J. & Omdahl, J.L. (1987) Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women. Journal of Clinical Endocrinology and Metabolism, 65, 724-731.
12. Esteban, N.V., Loughlin, T., Yergey, Al Zawadzki, J.K., Booth, J.D., Winterer, J.C. & Loriaux, D.L. (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 72, 1693-1700.
13. Fain, J.H. (1979) Inhibition of glucose transport in fat cells and activation of lipolysis by glucocorticoids. In: Glucocorticoid Hormone Action (eds J.D. Baxter & G.G. Rousseauk), p. 547. Springer-Verlag, New York.
14. Hauache, O.M., Amarante, E.C., Vieira, J.C., Farsen, S.M., Fernades, A.L., Jardin, J.R. & Lazaretti-Castro, M. (1999) Evaluation of bone metabolism after the use of an inhaled glucocorticoid (Flunisolide) in patients with moderate asthma. Clinical Endocrinology, 51, 35-39.
15. Hodsman, A.B. & Steer, B.M. (1993) Early histomorphometric changes in response to parathyroid hormone therapy; evidence for de novo bone formation on quiescent cancellous surfaces. Bone, 14, 523-527.
16. Kerrigan, J.R., Veldhuis, J.D., Leyo, S.A., Iranmanesh, A. & Rogol, A.D. (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. Journal of Clinical Endocrinology and Metabolism, 76, 1505-1510.
17. Kinash, B. & Haist, R.E. (1954) Effects of ACTH and cortisone on islets of Langerhans and pancreas in intact and hypophysectomized rats. American Journal of Physiology, 178, 441-444.
18. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosen, T., Lindstedt, G., Lundberg, P.A., Wilske, J. & Bengtsson, B.A. (1995) Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life style factors, blood pressure, and vitamin D. Calcified Tissue International, 56, 104-108.
19. Lane, N.E., Sanchez, S., Modin, G.W., Genent, H.K., Pierini, E. & Arnaud, C. (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Journal of Clinical Investigation, 102, 1627-1633.
20. Lukert, B.P. & Raisz, L.G. (1990) Glucocorticoid induced osteoporosis: pathogenesis and management. Annals of International Medicine, 112, 352-364.
21. Manelli, F., Bossoni, S., Bugari, G., Carpinteri, R., Godi, D., Agabiti Rosei, E., Veldhuis, J.D. & Giustina, A. (2001) Chronic glucocorticoid treatment alters the spontaneous pulsatile parathyroid hormone (PTH) secretory pattern in humans. In: Proceedings of the 83rd Annual Meeting of the Endocrine Society, Denver, CO, p. 125 (Abstract).
22. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.L. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419.
23. McConnell, E.M., Bell, P.M., Ennis, C., Hadden, D.R., McCance, D.R., Sheridan, B. & Atkinson, A.B. (2002) Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clinical Endocrinology, 56, 195-201.
24. Meikle, A.W. & Tyler, F.H. (1977) Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary adrenal function. American Journal of Medicine, 63, 200-207.
25. Munck, A. (1962) Studies on mode of action of glucocorticoids in rats. The effects in vivo and in vitro on net glucose uptake by isolated adipose tissue. Biochemica et Biophysica Acta, 57, 318-326.
26. 3 plus prednisone on serum osteocalcin in normal individuals. Journal of Bone Mineral Research, 6, 435-441.
27. Oelkers, W. (1996) Adrenal insufficiency. New England Journal of Medicine, 335, 1206-1212.
28. Olefsky, J.M. (1975) Effects of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. Journal of Clinical Investigation, 56, 1499-1508.
29. Perley, M. & Kipnis, D.M. (1966) Effects of glucocorticoids on plasma insulin. New England Journal of Medicine, 274, 1237-1241.
30. Sakoda, H., Ogihara, T., Anai, M., Funaki, M., Inukai, K., Kaagiri, H., Fukushima, Y., Onishi, Y., Ono, H., Fujishiro, M., Kikuchi, M., Oka, Y. & Asano, T. (2000) Dexamethasone induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes, 49, 1700-1708.
31. Sönksen, P.H. (1990) Replacement therapy in hypothalamo-pituitary insufficiency after childhood: management in the adult. Hormone Research, 33, 45-51.
32. Sugimoto, T., Brown, A.J., Ritter, C., Morrissey, J., Slatopolsky, E. & Martin, K.J. (1989) Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology, 125, 638-641.
33. Tyake, J.A. & Katz, J. (1997) Glucose production recycling, Cori cycle and gluconeogenesis in humans: relationship to serum cortisol. American Journal of Physiology, 272, 476-484.
34. Van Staa, T.P., Leufkens, H.G.M., Abenhaim, L., Zhang, B. & Cooper, C. (2000) Use of oral corticosteroids and risk of fractures. Journal of Bone Mineral Research, 15, 993-1000.
35. Varnic, M. (1965) Effect of cortisol in guinea-pigs with normal and atrophic exocrine pancreas. Diabetes, 14, 194-200.
36. Volk, B.W. & Lazarus, S.S. (1959) Morphologic reflections of increasing insulino-genesis during chronic hyperglycaemia in rabbit. Annals of the New York Academy of Science, 8, 319-328.
37. Zelissen, P.M., Croughs, R.J., Van Rajik, P.P. & Raymakers, J.A. (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison's disease. Annals of Internal Medicine, 120, 207-210.